AEQUITA PHARMACY recalls

13 recalls on record · latest: July 18, 2025

Official U.S. recall history for AEQUITA PHARMACY, compiled from official government records.

Get recall alerts

Free email alert whenever AEQUITA PHARMACY has a new recall — straight from official government data. Unsubscribe anytime.

AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) s…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.

AEQUITA PHARMACY recalls Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile…

July 18, 2025 · Drug & medication recalls Moderate risk Lack of Processing Controls.